FDA-Drug2026-07-01Class IIPROCESSING DEFECT
Amgen Sensipar 60mg tablets recalled for manufacturing quality deviations
OTHERNationwide distribution
Amgen Sensipar tablets recalled for manufacturing deviations
Amgen is recalling Sensipar (cinacalcet) 60mg tablets due to deviations from manufacturing standards. The recall affects one lot (1157055) with an expiration date of January 31, 2028, distributed nationwide.
- Check if you have Sensipar lot #1157055 (expiration 1/31/2028).
- Do not stop taking your medication without consulting your doctor.
- Contact your pharmacy or Amgen for instructions on replacement or verification.
Hazard
CGMP Deviations
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
1 Amgen Center Dr, N/A, Thousand Oaks, CA, United States
Products
Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0614-2026More Amgen, Inc. recalls
- FDA-Drug2026-07-01Amgen Corlanor (ivabradine) 7.5mg tablets recalled for foreign substance
- FDA-Drug2026-07-01Amgen Corlanor (ivabradine) 5 mg tablets recalled for foreign substance contamination
- FDA-Drug2026-07-01Amgen Sensipar (cinacalcet) 90mg tablets recalled for manufacturing compliance issues
- FDA-Drug2026-07-01Amgen Sensipar (cinacalcet) 30mg tablets recalled for manufacturing quality deviations
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief